Century Therapeutics IPSC
NASDAQ IPSC
$1.58 -0.03 (-1.86%)
At close: Oct 22, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Interest Expenses (2020 - 2023)

Updated

Century Therapeutics' Interest Expenses was $540,000 in FY2023.

Analysis

Century Therapeutics (IPSC) Interest Expenses (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Century Therapeutics 322.04 Mn -182.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 136,000.00
Mar 31, 2023 404,000.00
Sep 30, 2022 373,000.00
Jun 30, 2022 330,000.00
Mar 31, 2022 314,000.00
Sep 30, 2021 322,000.00
Jun 30, 2021 318,000.00
Sep 30, 2020 59,000.00
API Access

Century Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=IPSC&period=max&api_key=YOUR_API_KEY